Mumbai, June 22, 2017: Pharma Major Lupin Limited (Lupin) announced today the launch of its Desoximetasone Cream USP, 0.05% and Desoximetasone Cream
USP, 0.25% having received an approval from the United States Food and Drug Administration (FDA) earlier.
Desoximetasone Cream USP, 0.05% and Desoximetasone Cream USP, 0.25% are the AB rated generic equivalent of Taro Pharmaceuticals North America, Inc’s Topicort® LP Emollient Cream, 0.05% and Taro Pharmaceuticals, Inc’s (collectively Taro) Topicort® Cream, 0.25%. Both products are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Topicort® LP Emollient Cream and Topicort® Cream had combined US sales of USD 38 million (IMS MAT April 2017).
Corporate Comm India(CCI Newswire)
New Delhi, January 10, 2025: Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic healthcare…
By Srinath Rao, Senior Vice President, CitiusTech A few decades back, the purpose of watches…
Pharmapack Europe: 'Basel the best location for drug device innovation in Europe thanks to combination…
New Delhi, January 07, 2025: HMP virus can travel to the brain, or it can…
~ Co-authored by Dr Sanjith Saseedharan, Director-Critical Care, S. L. Raheja Hospital- A Fortis Associate…
Patients Embrace Flexibility with 37% of Online Doctor Consultations now happening even After 6 PM,…